It's also possible they really did make the revenue, but illegally leveraged the money into other businesses like the pharma company with same HK HQ address owned by the same CEO. The whole deal with getting a bank to allow a loan for one company to be backed by collateral from a cash balance for another company. With the same name of the CEO on both accounts, it sounds feasible if he was clever enough. If so, then the CEO has to find some other way to collateralize his debt with the other company, and do it fast.